Victory Financial Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$216K Buy
3,437
+603
+21% +$48.2K 0.03% 325
2025
Q4
$270K Buy
2,834
+618
+28% +$60.6K 0.03% 252
2025
Q3
$216K Buy
2,216
+278
+14% +$28.8K 0.03% 234
2025
Q2
$208K Sell
1,938
-157
-7% -$15.9K 0.03% 215
2025
Q1
$212K Buy
+2,095
New +$211K 0.04% 166

Other funds holding BSX

Victory Financial Group's BSX Position: Q1 2026 in Review

Victory Financial Group increased its Boston Scientific (BSX) stake by 21% in Q1 2026, buying an estimated $48.2K and bringing the position to 3,437 shares worth $216K. The position accounts for 0.03% of the portfolio, ranked #325.

Victory Financial Group first reported a position in BSX in Q1 2025 and has held it in 5 quarters since. The position peaked at $270K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Victory Financial Group held 3,437 shares of Boston Scientific worth $216K as of Q1 2026.
  • Victory Financial Group bought 603 Boston Scientific shares in Q1 2026, an estimated $48.2K.
  • Boston Scientific made up 0.03% of Victory Financial Group's portfolio in Q1 2026, its #325 holding.
  • Victory Financial Group first reported a position in Boston Scientific in Q1 2025 and has held it in 5 quarters since.
  • Victory Financial Group's Boston Scientific position peaked at $270K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Victory Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.